R76.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM R76.0 became effective on October 1, 2020. This is the American ICD-10-CM version of R76.0 - other international versions of ICD-10 R76.0 may differ. Type 1 Excludes
D68.61 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM D68.61 became effective on October 1, 2020. This is the American ICD-10-CM version of D68.61 - other international versions of ICD-10 D68.61 may differ. A type 1 excludes note is a pure excludes.
lupus anticoagulant (LAC) with hemorrhagic disorder ( ICD-10-CM Diagnosis Code D68.312. Antiphospholipid antibody with hemorrhagic disorder 2016 2017 2018 2019 Billable/Specific Code. Applicable To Lupus anticoagulant (LAC) with hemorrhagic disorder.
Antiphospholipid antibody with hemorrhagic disorder D68. 312 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D68. 312 became effective on October 1, 2021.
Definition. The antiphospholipid (anticardiolipin) syndrome (APS) is characterized by recurrent venous or arterial thrombosis (clots), recurrent fetal loss, and thrombocytopenia (a reduction in the number of platelets).
Cardiolipin antibodies are autoantibodies produced by the immune system that mistakenly target the body's own cardiolipins, substances found in the outermost layer of cells (cell membranes) and platelets. These autoantibodies can affect the body's ability to regulate blood clotting in a way that is not well understood.
A cardiolipin antibodies test looks for a certain kind of antibody in your blood. An antibody is a substance in your blood that helps fight off infection. The antibodies attack cardiolipins by mistake. Cardiolipin is a phospholipid, or a kind of fat in the blood that is important for blood clotting.
The phospholipid cardiolipin (CL) is a hallmark lipid of mitochondria and almost exclusively found in mitochondrial membranes (Pangborn, 1945). CL is predominantly located in the inner membrane and associated to many mitochondrial functions (see below).
Cardiolipin is a phospholipid, or a kind of fat in the blood. The levels of these antibodies are often high in people with abnormal blood clotting, autoimmune diseases like lupus, or repeated miscarriages.
The cardiolipin antibodies blood test, IgA, IgG, and IgM is used to help investigate inappropriate blood clot formation, to help determine the cause of recurrent miscarriage, or as part of an evaluation for antiphospholipid syndrome or sometimes other autoimmune diseases.
- Moderately or very high levels of anticardiolipin antibodies that persist for 12 weeks or more indicate a continued presence of these autoantibodies and an increased risk of abnormal clots and miscarriages.
Reference Interval<=12 MPLNegative13-19 MPLIndeterminate20-80 MPLLow to Moderately Positive81 MPL or aboveHigh Positive
It is now widely accepted that cardiolipin plays a central role in mitochondrial metabolism, by maintaining the proper architecture and morphology of the mitochondrial membranes and by regulating the activity of a variety of proteins and enzymes involved in mitochondrial function.
Anticardiolipins are antibodies produced by the immune system against the platelet membrane phospholipids responsible for the coagulation of blood clots.
Description. The Anticardiolipin Antibodies Test, or ACA Blood Test, aids in the diagnosis of antiphospholipid syndrome (APS). APS is an autoimmune disorder that produces anticardiolipin antibodies. These antibodies interfere with the blood clotting process, which can result in inappropriate or excessive clotting.
The 2022 edition of ICD-10-CM O99.11 became effective on October 1, 2021.
O99.1 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pre gnancy, childbirth and the puerperium. O99.11 Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy.
2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code. O99.11 should not be used for rei mbursement purposes as there are multiple codes below it that contain a greater level of detail.
The 2022 edition of ICD-10-CM D68.62 became effective on October 1, 2021.
D50-D89 Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism